Social Interaction and Communities of Practice in Formative Period NW Argentina: A Multi-analytical Study of Ceramics

This is the author accepted manuscript. The final version is available from University of New Mexico Press via the link in this recordThe study of long-distance exchange of goods and resources has long been central to the understanding of socio-political and cultural complexity in the south-central Andes. Traditional studies have emphasized typological similarities to reconstruct regional networks, proposing the dominance of different centres through time. While these approaches were informative on the general direction of contacts, the nature and scale of interaction has remained speculative. This chapter summarises the latest results of our ongoing research project on long-distance circulation of archaeological materials in northwestern Argentina during part of the Formative Period (ca. 1500 BC-AD 1000). The study applied a multianalytical methodological strategy integrating archaeological analysis with archaeometric techniques, including thin section petrography, instrumental neutron activation analysis (INAA) and laser ablation inductively coupled massspectometry (LA-ICP-MS) in order to contribute an evidence-based holistic view of preHispanic exchange networks. The study examined materials traditionally studied separately, including 542 ceramic samples and 113 obsidian and volcanic rock artifacts, from seven sectors in the semi-arid valleys area. We summarize here the results of the ceramic analysis, showing the 19-2 following trends: (1) inter-valley heterogeneity of clay and fabrics for ordinary wares; (2) intervalley homogeneity of clay and fabrics for a wide range of decorated wares; (3) selective circulation of two distinct polychrome wares. These trends reflect the complex inter-community relationships experienced in small-scale societies. The study offers a new platform to model ancient exchange, and circulation and interaction more broadly, based on actual material transfers. The results call for the re-examination of the centralized models of exchange and interaction that are often drawn upon to account for emergent cultural complexity in the past, both in the Andes and beyond.British AcademyArts and Humanities Research Council (AHRC)Argentinean National Agency for Science and Technology (ANPCyT)Raíces ProgramArgentinian National Council for Scientific and Technical Research (CONICET

Archaeology, Architecture, and the Postcolonial Critique

Peer reviewe

Contrast-enhanced ultrasound findings in soft-tissue lesions: preliminary results.

Objectives There is currently no widely available, minimally invasive first-level examination that allows physicians to identify soft-tissue lesions that are likely to be malignant. The aim of this pilot study was to explore the potential suitability of dynamic contrast-enhanced ultrasound (DCE-US) for this purpose. Materials and methods 23 patients were referred to the Veneto Oncological Institute for work-up of superficial soft-tissue lesions. Fourteen lesions were examined with CEUS and enhancement kinetics was analyzed. Subsequently, all lesions were surgically removed and subjected to histological analysis. Results The 14 lesions included in the study were histologically classified as malignant (n = 7) or benign (n = 7, including 3 schwannomas). A statistically significant difference between benign and malignant lesions was found in terms of mean times to peak enhancement intensity (p = 0.03) but not mean filling times (FT). When schwannomas were analyzed as a separate group, their mean FT was found to be significantly different from that of the other benign lesions (p = 0.001) and from that of the group comprising other benign lesions as well as malignant lesions (p < 0.005). Conclusions CEUS with analysis of contrast-enhancement kinetics is a relatively low-cost, minimally invasive imaging technique, which appears to be a potentially effective first-level method for identifying suspicious soft-tissue masses

Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register.

BACKGROUND: The RePoSi study has provided data on comorbidities, polypharmacy, and sex dimorphism in hospitalised elderly patients. METHODS: We retrospectively analysed data collected from the 2010, 2012, 2014, and 2016 data sets of the RePoSi register. The aim of this study was to explore the sex-differences and to validate the multivariate model in the entire dataset with an expanded follow-up at 1 year. RESULTS: Among 4714 patients, 51% were women and 49% were men. The disease distribution showed that diabetes, coronary artery disease, chronic obstructive pulmonary disease, chronic kidney disease, and malignancy were more frequent in men but that hypertension, anaemia, osteoarthritis, depression, and diverticulitis disease were more common in women. Severity and comorbidity indexes according to the Cumulative Illness Rating Scale (CIRS-s and CIRS-c) were higher in men, while cognitive impairment, mood disorders, and disability in daily life measured by the Barthel Index (BI) were worse in women. In the multivariate analysis, BI, CIRS, and malignancy significantly increased the risk of death in men at the 1-year follow-up, while age was independently associated with mortality in women. CONCLUSIONS: Our study highlighted the relevance and the validity of our previous predictive model in the identification of sex dimorphism in hospitalised elderly patients underscoring the need of sex-personalised health-care

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study

Lymphoma represents a heterogeneous hematological malignancy (HM), which is characterized by severe immunosuppression. Patients diagnosed of coronavirus disease 2019 (COVID-19) during the course of HM have been described to have poor outcome, with only few reports specifically addressing lymphoma patients. Here, we investigated the clinical behavior and clinical parameters of a large multicenter cohort of adult patients with different lymphoma subtypes, with the aim of identifying predictors of death. The study included 856 patients, of whom 619 were enrolled prospectively in a 1-year frame and were followed-up for a median of 66 days (range 1-395). Patients were managed as outpatient (not-admitted cohort, n = 388) or required hospitalization (n = 468), and median age was 63 years (range 19-94). Overall, the 30-and 100-days mortality was 13% (95% confi-dence interval (CI), 11% to 15%) and 23% (95% CI, 20% to 27%), respectively. Antilymphoma treatment, including anti-CD20 containing regimens, did not impact survival. Patients with Hodgkin's lymphoma had the more favorable survival, but this was partly related to signifi-cantly younger age. The time interval between lymphoma diagnosis and COVID-19 was inversely related to mortality. Multivariable analysis recognized 4 easy-to-use factors (age, gender, lymphocyte, and platelet count) that were associated with risk of death, both in the admitted and in the not-admitted cohort (HR 3.79 and 8.85 for the intermediate-and high risk group, respectively). Overall, our study shows that patients should not be deprived of the best available treatment of their underlying disease and indicates which patients are at higher risk of death. This study was registered with ClinicalTrials.gov, NCT04352556

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Background: Several small studies on patients with COVID-19 and haematological malignancies are available showing a high mortality in this population. The Italian Hematology Alliance on COVID-19 aimed to collect data from adult patients with haematological malignancies who required hospitalisation for COVID-19. Methods: This multicentre, retrospective, cohort study included adult patients (aged 6518 years) with diagnosis of a WHO-defined haematological malignancy admitted to 66 Italian hospitals between Feb 25 and May 18, 2020, with laboratory-confirmed and symptomatic COVID-19. Data cutoff for this analysis was June 22, 2020. The primary outcome was mortality and evaluation of potential predictive parameters of mortality. We calculated standardised mortality ratios between observed death in the study cohort and expected death by applying stratum-specific mortality rates of the Italian population with COVID-19 and an Italian cohort of 31 993 patients with haematological malignancies without COVID-19 (data up to March 1, 2019). Multivariable Cox proportional hazards model was used to identify factors associated with overall survival. This study is registered with ClinicalTrials.gov, NCT04352556, and the prospective part of the study is ongoing. Findings: We enrolled 536 patients with a median follow-up of 20 days (IQR 10\u201334) at data cutoff, 85 (16%) of whom were managed as outpatients. 440 (98%) of 451 hospitalised patients completed their hospital course (were either discharged alive or died). 198 (37%) of 536 patients died. When compared with the general Italian population with COVID-19, the standardised mortality ratio was 2\ub704 (95% CI 1\ub777\u20132\ub734) in our whole study cohort and 3\ub772 (2\ub786\u20134\ub764) in individuals younger than 70 years. When compared with the non-COVID-19 cohort with haematological malignancies, the standardised mortality ratio was 41\ub73 (38\ub71\u201344\ub79). Older age (hazard ratio 1\ub703, 95% CI 1\ub701\u20131\ub705); progressive disease status (2\ub710, 1\ub741\u20133\ub712); diagnosis of acute myeloid leukaemia (3\ub749, 1\ub756\u20137\ub781), indolent non-Hodgin lymphoma (2\ub719, 1\ub707\u20134\ub748), aggressive non-Hodgkin lymphoma (2\ub756, 1\ub734\u20134\ub789), or plasma cell neoplasms (2\ub748, 1\ub731\u20134\ub769), and severe or critical COVID-19 (4\ub708, 2\ub773\u20136\ub709) were associated with worse overall survival. Interpretation: This study adds to the evidence that patients with haematological malignancies have worse outcomes than both the general population with COVID-19 and patients with haematological malignancies without COVID-19. The high mortality among patients with haematological malignancies hospitalised with COVID-19 highlights the need for aggressive infection prevention strategies, at least until effective vaccination or treatment strategies are available. Funding: Associazione italiana contro le leucemie, linfomi e mieloma\u2013Varese Onlus